Quotes with Resistance & Support
Market Information

Shasun Chemicals top line grows by 32% at Rs 255.46cr

This article was posted on Jan 22, 2008 and is filed under Press Releases

Shasun Chemicals and Drugs Ltd; a leading pharma company focused on CRAMS and manufacture of finished dosage, APIs (active pharmaceutical ingredients) and the intermediates to global pharma, posted a 32 per cent growth in consolidated revenue at Rs.255.46 crores for the Q3FY08 compared to 194.06 crore in Q3FY07 and consolidated Profit after tax at Rs 11.88 crores for the Q3 FY08 as compared to Rs 11.65 crores of Q3FY07.

On Standalone basis, the company posted a growth of 24 per cent in revenue at Rs 128.58 crores for the Q3FY08 as compared to Rs 104.03 crores in Q3FY07. The net profit for the Q3FY08 stood at Rs 5.86 crores compared to Rs 10.02 crores in Q3FY07.

Nine Months Performance

On Consolidated basis for the nine months ended December 31, 2007, the company posted a 19 per cent growth in consolidated revenue at Rs 660.15 crores compared to Rs 555.28 in the corresponding period last year. The company posted a net profit of 4.83 crores for the nine months ended December 31, 2007 comparing to 35.08 crores in the corresponding period last year. However excluding the release of negative goodwill the loss is reduced to 1.94 crores compared to loss of Rs.15.62 Crores in the corresponding period last year.

Management Comments

The company has taken a research laboratory on long term lease basis in Piscataway, New Jersey. This new facility will provide Shasun to offer API development services for pre-clinical and clinical trial studies and also provide the backend support to company’s CRAM business and the same would be operational by March-08.

Event

Shasun will host the Fifth International Conference on Catalysis & Process Chemistry Technologies which will be held between March 30 and April 02 2008. The conference will focus on ‘asymmetric synthesis – metal coupling reaction and process intensification’ and will provide a forum for scientific exchange and the discussion of latest technologies, developments, and challenges on the topic.

Sourced From: Adfactors Public Relations Pvt Ltd

Tags: , , , ,

Similar Posts:

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments